Showing results (1431-1440 of 1,482) with videos related to

Sort By:
Pageof 149
NPJ Systems Biology and Applications|November 11, 2020
Mitochondria interaction networks show altered topological patterns in Parkinson's diseaseMassimiliano Zanin, Bruno F R Santos, Paul M A Antony, et al.
Protein Science : a Publication of the Protein Society|December 26, 2024
Exploring the druggability of the UEV domain of human TSG101 in search for broad-spectrum antiviralsFernando Montero, Marisa Parra-López, Alejandro Rodríguez-Martínez, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|April 13, 2005
Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registryBernhard Reimers, Horst Sievert, Gerhard C Schuler, et al.
Journal of Medicinal Chemistry|January 7, 2014
Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cellsSergio Valente, Yiwei Liu, Michael Schnekenburger, et al.
Molecular Neurobiology|July 9, 2013
Integrating pathways of Parkinson's disease in a molecular interaction mapKazuhiro A Fujita, Marek Ostaszewski, Yukiko Matsuoka, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 25, 2019
Quality assurance guidelines for interstitial hyperthermiaH Dobšíček Trefná, M Schmidt, G C van Rhoon, et al.
Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Frontiers in Pharmacology|March 17, 2018
Cardiac Glycoside Glucoevatromonoside Induces Cancer Type-Specific Cell DeathNaira F Z Schneider, Claudia Cerella, Jin-Young Lee, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 5, 2017
Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirementsHana Dobšíček Trefná, Hans Crezee, Manfred Schmidt, et al.
Pageof 149